PRAF2 as a novel biomarker for breast cancer with machine learning and experimentation validation

PRAF2 as a novel biomarker for breast cancer with machine learning and experimentation validation

Abstract Background Breast cancer (BC) is the most prevalent malignancy in women. Potential therapeutic targets for BC are of great significance. In our previous study, we found that prenylated rab acceptor 1 domain family member 2 (PRAF2) is an oncogene in BC. However, the exact mechanism of PRAF2...

Full description

Saved in:
Bibliographic Details
Main Authors: Zheng Wang, Zilin Bi, Hongguang Bo, Junyi Xu, Rui Sha, Zhaocai Yin, Changsheng Yu, Yufa Xu, Xiaomeng Shi, Wenbo Song, Bin Chen, Yabing Wang, Qian Zhang, Jianping Chen
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
PRAF2
Breast cancer
Molecular target
Immune infiltration
Novel biomarker
Online Access:https://doi.org/10.1186/s12885-024-13258-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13258-7

Similar Items